Teriparatide acetate

醋酸特立帕肽

Report date: 2026/02/25 20:02:36

Base Information

Drug NameTeriparatide acetate
Drug Alias NameParatharTeribonehPTH (1-34) acet. H2OAK-159MN-10-T
ClassificationSmall molecules > Synthetic peptideDiagnostic agent (In vivo)
Mechanisms of ActionParathyroid hormone replacements
TargetsParathyroid hormone receptor
Therapy Area/IndicationsHypocalcemiaOsteoporosis
Global Approved IndicationsHypocalcemiaOsteoporosis
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date1987/03/31
Country/TerritoryJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesUnion Square Ventures Llc
China Registration ClassN/A

Develop Information

Active CompaniesMAIA Pharmaceuticals Inc
Inactive CompaniesAsahi Kasei Pharma America Corp
Active IndicationsHypocalcemiaOsteoporosis
Inactive IndicationsN/A

Other Information

ATC CodeH05AA02
Related LinksWikipediaDrugBankKEGG